International Assets Investment Management LLC Invests $305,000 in VanEck Biotech ETF (NASDAQ:BBH)

International Assets Investment Management LLC bought a new stake in VanEck Biotech ETF (NASDAQ:BBH) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 1,845 shares of the company’s stock, valued at approximately $305,000. International Assets Investment Management LLC owned 0.06% of VanEck Biotech ETF at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Private Advisor Group LLC increased its holdings in VanEck Biotech ETF by 4.7% in the third quarter. Private Advisor Group LLC now owns 1,675 shares of the company’s stock valued at $261,000 after buying an additional 75 shares during the last quarter. Anchor Investment Management LLC acquired a new stake in shares of VanEck Biotech ETF during the 4th quarter worth about $26,000. Altfest L J & Co. Inc. lifted its stake in VanEck Biotech ETF by 3.7% during the third quarter. Altfest L J & Co. Inc. now owns 7,657 shares of the company’s stock worth $1,192,000 after purchasing an additional 274 shares during the last quarter. Kestra Advisory Services LLC lifted its stake in VanEck Biotech ETF by 16.1% during the third quarter. Kestra Advisory Services LLC now owns 3,061 shares of the company’s stock worth $477,000 after purchasing an additional 424 shares during the last quarter. Finally, Commonwealth Equity Services LLC boosted its holdings in VanEck Biotech ETF by 1.8% in the third quarter. Commonwealth Equity Services LLC now owns 28,705 shares of the company’s stock valued at $4,470,000 after purchasing an additional 495 shares in the last quarter. 32.05% of the stock is owned by institutional investors and hedge funds.

VanEck Biotech ETF Price Performance

BBH stock opened at $155.59 on Friday. VanEck Biotech ETF has a twelve month low of $142.51 and a twelve month high of $171.04. The company’s 50 day moving average is $162.21 and its two-hundred day moving average is $159.75.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.